Radiopharm Theranostics RADX
NASDAQ RADX
$1.49 -0.13 (-8.02%)
As of: Oct 1, 2026 · 12:00 PM EDT

Radiopharm Theranostics (RADX) Times Interest Earned (2023 - 2026)

Updated

Radiopharm Theranostics' (RADX) Times Interest Earned was -505.21 for FY2026 (year ended Jun 30, 2026), compared with -584.59 in FY2025.

Analysis

Radiopharm Theranostics (RADX) Times Interest Earned (2023 - 2026) Analysis & Trends

Dating back to FY2023, Radiopharm Theranostics' Times Interest Earned record includes 4 fiscal years.

  • Five-year annual Times Interest Earned spans a low of -584.59 in FY2025 and a high of -73.43 in FY2024.
  • According to Business Quant data, Times Interest Earned came in at -584.59 in FY2025, -73.43 in FY2024 and -400.59 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 -505.21
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -505.21
Jun 30, 2025 -584.59
Jun 30, 2024 -73.43
Jun 30, 2023 -400.59
API Access

Radiopharm Theranostics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=RADX&period=max&api_key=YOUR_API_KEY